Skip to main content
Erschienen in: Inflammation 1/2022

03.09.2021 | Original Article

Exosomes Derived from ADSCs Attenuate Sepsis-Induced Lung Injury by Delivery of Circ-Fryl and Regulation of the miR-490-3p/SIRT3 Pathway

verfasst von: Weijun Shen, Xuan Zhao, Shitong Li

Erschienen in: Inflammation | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract—

Sepsis-induced lung injury is a clinical syndrome characterized by injury of alveolar epithelium cells (AECs). Previous investigations illustrate that exosomes secreted from adipose-derived stem cells (ADSCs) have therapeutic effects in a variety of disease treatments, but roles and mechanisms regarding ADSC-derived exosomes in sepsis-induced lung injury are unclear. In this study, high-throughput sequencing was used to explore the molecular delivery of ADSC exosomes. A sepsis-induced lung injury mouse model and a lipopolysaccharide-induced AEC damage model were used for mechanistic analysis. The results showed that ADSC exosomes have high levels of the circular RNA (circ)-Fryl. Downregulation of circ-Fryl suppressed ADSC protective effects exosomes against sepsis-induced lung injury by decreasing apoptosis and inflammatory factor expression. Bioinformatics and luciferase reporting experiments showed that miR-490-3p and SIRT3 are downstream targets of circ-Fryl. miR-490-3p overexpression or SIRT3 silencing reversed ADSC exosome protective effects. Studying the mechanism showed that overexpression of circ-Fryl promoted autophagy activation by inducing SIRT3/AMPK signaling. Autophagy activation can suppress sepsis-induced lung injury by decreasing apoptosis and inflammatory factor expression. Taken together, our results suggest that exosomes derived from ADSCs attenuate sepsis-induced lung injury by delivery of circ-Fryl and regulation of the miR-490-3p/SIRT3 pathway.
Literatur
1.
Zurück zum Zitat Christ-Crain, M., N.G. Morgenthaler, J. Struck, S. Harbarth, A. Bergmann, and B. Muller. 2005. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: An observational study. Critical Care 9: R816–R824.CrossRef Christ-Crain, M., N.G. Morgenthaler, J. Struck, S. Harbarth, A. Bergmann, and B. Muller. 2005. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: An observational study. Critical Care 9: R816–R824.CrossRef
2.
Zurück zum Zitat Lou, L., D. Hu, S. Chen, S. Wang, Y. Xu, Y. Huang, et al. 2019. Protective role of JNK inhibitor SP600125 in sepsis-induced acute lung injury. International Journal of Clinical and Experimental Pathology 12: 528–538.PubMedPubMedCentral Lou, L., D. Hu, S. Chen, S. Wang, Y. Xu, Y. Huang, et al. 2019. Protective role of JNK inhibitor SP600125 in sepsis-induced acute lung injury. International Journal of Clinical and Experimental Pathology 12: 528–538.PubMedPubMedCentral
3.
Zurück zum Zitat Jang, E.A., J.Y. Kim, T.D. Tin, J.A. Song, S.H. Lee, and S.H. Kwak. 2019. The effects of BMS-470539 on lipopolysaccharide-induced acute lung injury. Acute Crit Care 34: 133–140.CrossRef Jang, E.A., J.Y. Kim, T.D. Tin, J.A. Song, S.H. Lee, and S.H. Kwak. 2019. The effects of BMS-470539 on lipopolysaccharide-induced acute lung injury. Acute Crit Care 34: 133–140.CrossRef
4.
Zurück zum Zitat Janicova, A., N. Becker, B. Xu, S. Wutzler, J.T. Vollrath, F. Hildebrand, et al. 2019. Endogenous uteroglobin as intrinsic anti-inflammatory signal modulates monocyte and macrophage subsets distribution upon sepsis induced lung injury. Frontiers in Immunology 10: 2276.CrossRef Janicova, A., N. Becker, B. Xu, S. Wutzler, J.T. Vollrath, F. Hildebrand, et al. 2019. Endogenous uteroglobin as intrinsic anti-inflammatory signal modulates monocyte and macrophage subsets distribution upon sepsis induced lung injury. Frontiers in Immunology 10: 2276.CrossRef
5.
Zurück zum Zitat Yen, Y.T., H.R. Yang, H.C. Lo, Y.C. Hsieh, S.C. Tsai, C.W. Hong, et al. 2013. Enhancing autophagy with activated protein C and rapamycin protects against sepsis-induced acute lung injury. Surgery 153: 689–698.CrossRef Yen, Y.T., H.R. Yang, H.C. Lo, Y.C. Hsieh, S.C. Tsai, C.W. Hong, et al. 2013. Enhancing autophagy with activated protein C and rapamycin protects against sepsis-induced acute lung injury. Surgery 153: 689–698.CrossRef
6.
Zurück zum Zitat Wang, W., X. Yang, Q. Chen, M. Guo, S. Liu, J. Liu, et al. 2020. Sinomenine attenuates septic-associated lung injury through the Nrf2-Keap1 and autophagy. Journal of Pharmacy and Pharmacology 72: 259–270.CrossRef Wang, W., X. Yang, Q. Chen, M. Guo, S. Liu, J. Liu, et al. 2020. Sinomenine attenuates septic-associated lung injury through the Nrf2-Keap1 and autophagy. Journal of Pharmacy and Pharmacology 72: 259–270.CrossRef
7.
Zurück zum Zitat Chen, H.H., P.F. Lai, Y.F. Lan, C.F. Cheng, W.B. Zhong, Y.F. Lin, et al. 2014. Exosomal ATF3 RNA attenuates pro-inflammatory gene MCP-1 transcription in renal ischemia-reperfusion. Journal of Cellular Physiology 229: 1202–1211.CrossRef Chen, H.H., P.F. Lai, Y.F. Lan, C.F. Cheng, W.B. Zhong, Y.F. Lin, et al. 2014. Exosomal ATF3 RNA attenuates pro-inflammatory gene MCP-1 transcription in renal ischemia-reperfusion. Journal of Cellular Physiology 229: 1202–1211.CrossRef
8.
Zurück zum Zitat Chen, K.H., C.H. Chen, C.G. Wallace, C.M. Yuen, G.S. Kao, Y.L. Chen, et al. 2016. Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke. Oncotarget 7: 74537–74556.CrossRef Chen, K.H., C.H. Chen, C.G. Wallace, C.M. Yuen, G.S. Kao, Y.L. Chen, et al. 2016. Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke. Oncotarget 7: 74537–74556.CrossRef
9.
Zurück zum Zitat Fleig, S.V., and B.D. Humphreys. 2014. Rationale of mesenchymal stem cell therapy in kidney injury. Nephron Clinical Practice 127: 75–80.CrossRef Fleig, S.V., and B.D. Humphreys. 2014. Rationale of mesenchymal stem cell therapy in kidney injury. Nephron Clinical Practice 127: 75–80.CrossRef
10.
Zurück zum Zitat Geng, W., H. Tang, S. Luo, Y. Lv, D. Liang, X. Kang, et al. 2019. Exosomes from miRNA-126-modified ADSCs promotes functional recovery after stroke in rats by improving neurogenesis and suppressing microglia activation. American Journal of Translational Research 11: 780–792.PubMedPubMedCentral Geng, W., H. Tang, S. Luo, Y. Lv, D. Liang, X. Kang, et al. 2019. Exosomes from miRNA-126-modified ADSCs promotes functional recovery after stroke in rats by improving neurogenesis and suppressing microglia activation. American Journal of Translational Research 11: 780–792.PubMedPubMedCentral
11.
Zurück zum Zitat Shang, Y., Y. Sun, J. Xu, X. Ge, Z. Hu, J. Xiao, et al. 2020. Exosomes from mmu_circ_0001359-modified ADSCs attenuate airway remodeling by enhancing FoxO1 signaling-mediated M2-like macrophage activation. Molecular Therapy-Nucleic Acids 19: 951–960.CrossRef Shang, Y., Y. Sun, J. Xu, X. Ge, Z. Hu, J. Xiao, et al. 2020. Exosomes from mmu_circ_0001359-modified ADSCs attenuate airway remodeling by enhancing FoxO1 signaling-mediated M2-like macrophage activation. Molecular Therapy-Nucleic Acids 19: 951–960.CrossRef
12.
Zurück zum Zitat Meng, L., H. Cao, C. Wan, and L. Jiang. 2019. MiR-539-5p alleviates sepsis-induced acute lung injury by targeting ROCK1. Folia Histochemica et Cytobiologica 57: 168–178.CrossRef Meng, L., H. Cao, C. Wan, and L. Jiang. 2019. MiR-539-5p alleviates sepsis-induced acute lung injury by targeting ROCK1. Folia Histochemica et Cytobiologica 57: 168–178.CrossRef
13.
Zurück zum Zitat Zhang, Y.Y., X. Liu, X. Zhang, and J. Zhang. 2020. Shikonin improve sepsis-induced lung injury via regulation of miRNA-140-5p/TLR4—A vitro and vivo study. Journal of Cellular Biochemistry 121: 2103–2117.CrossRef Zhang, Y.Y., X. Liu, X. Zhang, and J. Zhang. 2020. Shikonin improve sepsis-induced lung injury via regulation of miRNA-140-5p/TLR4—A vitro and vivo study. Journal of Cellular Biochemistry 121: 2103–2117.CrossRef
14.
Zurück zum Zitat Jin, J., Y. Wang, L. Zhao, W. Zou, M. Tan, and Q. He. 2020. Exosomal miRNA-215-5p derived from adipose-derived stem cells attenuates epithelial-mesenchymal transition of podocytes by inhibiting ZEB2. BioMed Research International 2020: 2685305.PubMedPubMedCentral Jin, J., Y. Wang, L. Zhao, W. Zou, M. Tan, and Q. He. 2020. Exosomal miRNA-215-5p derived from adipose-derived stem cells attenuates epithelial-mesenchymal transition of podocytes by inhibiting ZEB2. BioMed Research International 2020: 2685305.PubMedPubMedCentral
15.
Zurück zum Zitat Avila-Portillo, L.M., F. Aristizabal, A. Riveros, M.C. Abba, and D. Correa. 2020. Modulation of adipose-derived mesenchymal stem/stromal cell transcriptome by G-CSF stimulation. Stem Cells International 2020: 5045124.CrossRef Avila-Portillo, L.M., F. Aristizabal, A. Riveros, M.C. Abba, and D. Correa. 2020. Modulation of adipose-derived mesenchymal stem/stromal cell transcriptome by G-CSF stimulation. Stem Cells International 2020: 5045124.CrossRef
16.
Zurück zum Zitat Chen, J., and M. Chopp. 2018. Exosome therapy for stroke. Stroke 49: 1083–1090.CrossRef Chen, J., and M. Chopp. 2018. Exosome therapy for stroke. Stroke 49: 1083–1090.CrossRef
17.
Zurück zum Zitat Yang, F., X. Liao, Y. Tian, and G. Li. 2017. Exosome separation using microfluidic systems: size-based, immunoaffinity-based and dynamic methodologies. Biotechnologu Journal 12. Yang, F., X. Liao, Y. Tian, and G. Li. 2017. Exosome separation using microfluidic systems: size-based, immunoaffinity-based and dynamic methodologies. Biotechnologu Journal 12.
18.
Zurück zum Zitat He, C., S. Zheng, Y. Luo, and B. Wang. 2018. Exosome theranostics: Biology and translational medicine. Theranostics 8: 237–255.CrossRef He, C., S. Zheng, Y. Luo, and B. Wang. 2018. Exosome theranostics: Biology and translational medicine. Theranostics 8: 237–255.CrossRef
19.
Zurück zum Zitat Bao, X., Q. Zhang, N. Liu, S. Zhuang, Z. Li, Q. Meng, et al. 2019. Characteristics of circular RNA expression of pulmonary macrophages in mice with sepsis-induced acute lung injury. Journal of Cellular and Molecular Medicine 23: 7111–7115.CrossRef Bao, X., Q. Zhang, N. Liu, S. Zhuang, Z. Li, Q. Meng, et al. 2019. Characteristics of circular RNA expression of pulmonary macrophages in mice with sepsis-induced acute lung injury. Journal of Cellular and Molecular Medicine 23: 7111–7115.CrossRef
20.
Zurück zum Zitat Cinar, I., B. Sirin, P. Aydin, E. Toktay, E. Cadirci, I. Halici, et al. 2019. Ameliorative effect of gossypin against acute lung injury in experimental sepsis model of rats. Life Sciences 221: 327–334.CrossRef Cinar, I., B. Sirin, P. Aydin, E. Toktay, E. Cadirci, I. Halici, et al. 2019. Ameliorative effect of gossypin against acute lung injury in experimental sepsis model of rats. Life Sciences 221: 327–334.CrossRef
21.
Zurück zum Zitat Cadirci, E., B.Z. Altunkaynak, Z. Halici, F. Odabasoglu, M.H. Uyanik, C. Gundogdu, et al. 2010. Alpha-lipoic acid as a potential target for the treatment of lung injury caused by cecal ligation and puncture-induced sepsis model in rats. Shock 33: 479–484.CrossRef Cadirci, E., B.Z. Altunkaynak, Z. Halici, F. Odabasoglu, M.H. Uyanik, C. Gundogdu, et al. 2010. Alpha-lipoic acid as a potential target for the treatment of lung injury caused by cecal ligation and puncture-induced sepsis model in rats. Shock 33: 479–484.CrossRef
22.
Zurück zum Zitat Park, E.J., M.G. Appiah, P.K. Myint, A. Gaowa, E. Kawamoto, and M. Shimaoka. 2019. Exosomes in sepsis and inflammatory tissue injury. Current Pharmaceutical Design 25: 4486–4495.CrossRef Park, E.J., M.G. Appiah, P.K. Myint, A. Gaowa, E. Kawamoto, and M. Shimaoka. 2019. Exosomes in sepsis and inflammatory tissue injury. Current Pharmaceutical Design 25: 4486–4495.CrossRef
23.
Zurück zum Zitat Zhang, R., Y. Zhu, Y. Li, W. Liu, L. Yin, S. Yin, et al. 2020. Human umbilical cord mesenchymal stem cell exosomes alleviate sepsis-associated acute kidney injury via regulating microRNA-146b expression. Biotechnology Letters 42: 669–679.CrossRef Zhang, R., Y. Zhu, Y. Li, W. Liu, L. Yin, S. Yin, et al. 2020. Human umbilical cord mesenchymal stem cell exosomes alleviate sepsis-associated acute kidney injury via regulating microRNA-146b expression. Biotechnology Letters 42: 669–679.CrossRef
24.
Zurück zum Zitat Chen, H.G., H.Z. Han, Y. Li, Y.H. Yu, and K.L. Xie. 2020. Hydrogen alleviated organ injury and dysfunction in sepsis: The role of cross-talk between autophagy and endoplasmic reticulum stress: Experimental research. International Immunopharmacol 78: 106049.CrossRef Chen, H.G., H.Z. Han, Y. Li, Y.H. Yu, and K.L. Xie. 2020. Hydrogen alleviated organ injury and dysfunction in sepsis: The role of cross-talk between autophagy and endoplasmic reticulum stress: Experimental research. International Immunopharmacol 78: 106049.CrossRef
25.
Zurück zum Zitat Duan, W.J., Y.F. Li, F.L. Liu, J. Deng, Y.P. Wu, W.L. Yuan, et al. 2016. A SIRT3/AMPK/autophagy network orchestrates the protective effects of trans-resveratrol in stressed peritoneal macrophages and RAW 2647 macrophages. Free Radical Biology and Medicine 95: 230–242.CrossRef Duan, W.J., Y.F. Li, F.L. Liu, J. Deng, Y.P. Wu, W.L. Yuan, et al. 2016. A SIRT3/AMPK/autophagy network orchestrates the protective effects of trans-resveratrol in stressed peritoneal macrophages and RAW 2647 macrophages. Free Radical Biology and Medicine 95: 230–242.CrossRef
26.
Zurück zum Zitat Zhao, W., L. Zhang, R. Chen, H. Lu, M. Sui, Y. Zhu, et al. 2018. SIRT3 protects against acute kidney injury via AMPK/mTOR-regulated autophagy. Frontiers in Physiology 9: 1526.CrossRef Zhao, W., L. Zhang, R. Chen, H. Lu, M. Sui, Y. Zhu, et al. 2018. SIRT3 protects against acute kidney injury via AMPK/mTOR-regulated autophagy. Frontiers in Physiology 9: 1526.CrossRef
Metadaten
Titel
Exosomes Derived from ADSCs Attenuate Sepsis-Induced Lung Injury by Delivery of Circ-Fryl and Regulation of the miR-490-3p/SIRT3 Pathway
verfasst von
Weijun Shen
Xuan Zhao
Shitong Li
Publikationsdatum
03.09.2021
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2022
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-021-01548-2

Weitere Artikel der Ausgabe 1/2022

Inflammation 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.